Publications database

  Filter by
 

Publication date

Series / Type

Language

Main subject

Keywords

Displaying 1 - 20 of 47
Monographs

Hepatitis C and injecting drug use: impact, costs and policy options

December 2004

Hepatitis C infections occurring in recent years in the European Union may cost countries billions of euros in future healthcare, according to research published in this monograph. A conglomeration of state-of-the-art research on hepatitis C, drug use and public health methods, this publication...
National reports

National report 2004: United Kingdom

December 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Sweden

December 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Slovakia

December 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Romania

December 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Bulgaria

December 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Malta

December 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Cyprus

December 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Greece

December 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
Selected issues

Co-morbidity

November 2004

The co-occurrence of psychiatric illness and substance disorders, commonly termed co-morbidity or dual diagnosis, is not a new phenomenon. However, in recent years the issue has gained momentum in the political and professional discussion as it has become apparent that a large and probably growing...
Selected issues

Cannabis problems in context: understanding the increase in European treatment demands

November 2004

The extent and nature of problems found within populations of European cannabis consumers remain unclear. Also unclear is the extent to which statistical information on increasing demands for treatment reflects changes in reporting and referral practice as opposed to increases in the number of...
Selected issues

Evaluation of 'national drug strategies' in Europe

November 2004

Many countries have recently adopted a ‘national drugs strategy’. This Selected issue focuses on plans for the evaluation of these strategies, which for the first time has been enabled on a European scale by work undertaken by the national focal points. This work has helped to clarify references to...
European Drug Report

2004 Annual report: the state of the drugs problem in the European Union and Norway

November 2004

The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published...
National reports

National report 2004: Denmark

November 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
Drugnet Europe

Drugnet Europe 48

October 2004

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and its key partners and carries features on the activities of the national focal points,...
National reports

National report 2004: Austria

October 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Slovenia

October 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Poland

October 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Norway

October 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2004: Belgium

October 2004

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...

Loading